Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO ...
| ELTX Stock | 8.18 0.34 4.34% |
Slightly above 56% of all Elicio Therapeutics' investors are looking to take a long position. The analysis of overall sentiment of trading Elicio Therapeutics stock suggests that some investors are interested at this time. Elicio Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Elicio Therapeutics' earnings reports, geopolitical events, and overall market trends.
Elicio |
Updated Phase 1 data include a 16.3-month median recurrence-free survival and 28.9-month median overall survival from full study popula
Read at gurufocus.com
 |
Elicio Therapeutics Fundamental Analysis
We analyze Elicio Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elicio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elicio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Elicio Therapeutics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Elicio Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elicio Therapeutics stock to make a market-neutral strategy. Peer analysis of Elicio Therapeutics could also be used in its relative valuation, which is a method of valuing Elicio Therapeutics by comparing valuation metrics with similar companies.
Peers
Elicio Therapeutics Related Equities
| PLYA | Playa Hotels | 0.22 |
| ||
| AMBI | Ambipar Emergency | 1.41 |
| ||
| FSK | FS KKR | 1.49 |
| ||
| WM | Waste Management | 1.63 |
| ||
| LRFC | Logan Ridge | 2.85 |
| ||
| SBUX | Starbucks | 2.90 |
|
Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.